clonidine has been researched along with mirtazapine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 14 (73.68) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nickolson, VJ; van Delft, AM; Wieringa, JH | 1 |
| Blier, P; de Montigny, C; Haddjeri, N | 1 |
| Abo-Zena, RA; Bobek, MB; Dweik, RA | 1 |
| Bengtsson, HJ; Hjorth, S; Johansson, J; Kele, J | 1 |
| Cornil, C; Dumont, F; Fontaine, E; Machowski, R; Mendlewicz, J; Schittecatte, M; Wilmotte, J | 1 |
| Bouvard, M; Rénéric, JP; Stinus, L | 1 |
| Nash, JR; Nutt, DJ; Potokar, JP; Wilson, SJ | 1 |
| Devoto, P; Flore, G; Gessa, GL; Longu, G; Pira, L | 1 |
| Ashkanian, M; Audrain, H; Bender, D; Hall, H; Hansen, SB; Jakobsen, S; Minuzzi, L; Rosenberg, R; Smith, DF; Stork, BS | 1 |
| Arora, S; Vohora, D | 1 |
1 review(s) available for clonidine and mirtazapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for clonidine and mirtazapine
| Article | Year |
|---|---|
Neuroimaging of mirtazapine enantiomers in humans.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Autoradiography; Binding Sites; Binding, Competitive; Brain; Carbon Radioisotopes; Clonidine; Double-Blind Method; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Positron-Emission Tomography; Radioligand Assay; Radiopharmaceuticals; Stereoisomerism; Tissue Distribution; Young Adult | 2008 |
17 other study(ies) available for clonidine and mirtazapine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.
Topics: Absorption; Aggression; Animals; Behavior, Animal; Brain; Cell Membrane; Clonidine; Dibenzazepines; Diuresis; Dopamine; Humans; In Vitro Techniques; Male; Mianserin; Mice; Mirtazapine; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Histamine; Serotonin | 1982 |
Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Clonidine; Dose-Response Relationship, Drug; Evoked Potentials; Hippocampus; Locus Coeruleus; Mianserin; Mirtazapine; Neural Pathways; Neurons; Norepinephrine; Raphe Nuclei; Rats; Receptors, Serotonin; Serotonin; Synaptic Transmission | 1998 |
Hypertensive urgency induced by an interaction of mirtazapine and clonidine.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Antidepressive Agents; Antihypertensive Agents; Clonidine; Depression; Drug Interactions; Humans; Hypertension; Male; Mianserin; Mirtazapine | 2000 |
Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Anesthesia; Animals; Antidepressive Agents, Tricyclic; Brain; Clonidine; Male; Mianserin; Microdialysis; Mirtazapine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Serotonin | 2000 |
Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha(2)-adrenergic receptors in depression.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Clonidine; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Mianserin; Mirtazapine; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Sleep, REM | 2002 |
In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Clonidine; Cyclopropanes; Depression; Desipramine; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Mianserin; Milnacipran; Mirtazapine; Motor Activity; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Swimming | 2002 |
Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Clonidine; Drug Administration Schedule; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Parkinsonian Disorders; Recurrence; REM Sleep Behavior Disorder; Treatment Outcome | 2003 |
Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Clonidine; Desipramine; Dopamine; Injections, Intraperitoneal; Male; Mianserin; Microdialysis; Mirtazapine; Neurons; Norepinephrine; Occipital Lobe; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 2004 |
Comparative Evaluation of Partial α2 -Adrenoceptor Agonist and Pure α2 -Adrenoceptor Antagonist on the Behavioural Symptoms of Withdrawal after Chronic Alcohol Administration in Mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Alcoholism; Animals; Anxiety; Behavior, Animal; Clonidine; Depression; Dose-Response Relationship, Drug; Male; Memory; Mianserin; Mice; Mirtazapine; Receptors, Adrenergic; Substance Withdrawal Syndrome | 2016 |